We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Universal Diagnostics Stock

Invest in or calculate the value of your shares in Universal Diagnostics or other pre-IPO companies through EquityZen's platform.

Get Started

Universal Diagnostics Stock (UNDI)

UDX is an in-vitro diagnostics company developing a platform of minimally-invasive, blood-based solutions for the early detection of cancer

About Universal Diagnostics Stock

Founded

2012

Industries

Science and Engineering, Health Care, Biotechnology

Universal Diagnostics S.L. (UDX) is a Spanish in-vitro diagnostics company developing a platform of minimally-invasive, blood-based solutions for detecting cancer early when treatment options are more plentiful and survival rates are still high. UDX believes that the best way to fight against cancer is by detecting it early. The UDX diagnostic platform is designed to detect various cancer types, e.g. colorectal, liver, pancreatic, lung, and gastric cancer via one simple blood test. The assays rely on a curated set of proprietary methylation marker panels; a simple blood sample collected as part of a routine check-up, can be processed at a reference laboratory or hospital using standard equipment and then uploaded to the UDX Cloud for final algorithmic analysis. UDX’s first marker panel is a colorectal cancer screening test. The test identifies individuals who need to be referred for colonoscopy. Colorectal cancer is the 3rd most frequent cancer and 2nd deadliest cancer worldwide. The challenge is that colorectal cancer is mostly detected in late stages, with significantly decreased survival rates (11% survival rate in stage IV vs. 85% survival rate in stage I). To develop the test and execute its R&D and operations, UDX partners with international research institutions, hospitals, universities, and biobanks around the globe.

Universal Diagnostics Press Mentions

Stay in the know about the latest news on Universal Diagnostics

Fighting for recognition | HCM editor's letter

healthclubmanagement • Dec 20, 2023

How AI is Shaping the Future of Genetics

therecursive • Dec 20, 2023

Universal Diagnostics Management

Leadership team at Universal Diagnostics

Founder and CTO

Marko Bitenc

COO

Christian Hense

Locked Features

Join now and verify your accreditation status to gain access to:

  • Universal Diagnostics current valuation
  • Universal Diagnostics stock price
  • Available deals in Universal Diagnostics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Universal Diagnostics stock?

Accredited investors can buy pre-IPO stock in companies like Universal Diagnostics through EquityZen funds. These investments are made available by existing Universal Diagnostics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Universal Diagnostics stock?

Shareholders can sell their Universal Diagnostics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."